Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome
- 15 September 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 128 (3), 703-711
- https://doi.org/10.1007/s10549-010-1154-y
Abstract
Macrophages, a key cell in the inflammatory cascade, have been associated with poor prognosis in cancers, including breast cancer. In this study, we investigated the relationship of a subset of macrophages—proliferating macrophages (promacs)—with clinico-pathologic characteristics of breast cancer, including tumor size, grade, stage, lymph node metastases, hormone receptor status, subtype, as well as early recurrence, and survival. This study included a discovery and validation set that was conducted at two institutions and laboratories (University of California, San Francisco and University of Chicago) using two independent cohorts of patients with breast cancer. Formalin-fixed, paraffin-embedded sections and/or tissue microarrays were double-stained with anti-CD68 (a macrophage marker) and anti-PCNA (a proliferation marker) antibodies. The presence of intratumoral promacs was significantly correlated with high grade, hormone receptor negative tumors, and a basal-like subtype. In contrast, there was no correlation between promacs and tumor size, stage, or the number of the involved lymph nodes. These findings were consistent between the two study cohorts. Finally, promac numbers were a significant predictor of recurrence and survival. In the pooled analysis, elevated promac levels were associated with a 77% increased risk of dying (P = 0.015). The presence of promacs in human breast cancer may serve as a prognostic indicator for poor outcomes and early recurrence and serve as a potential cellular target for novel therapeutic interventions.Keywords
This publication has 22 references indexed in Scilit:
- Distinct Role of Macrophages in Different Tumor MicroenvironmentsCancer Research, 2006
- Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)Blood, 2005
- Atheroma stabilizing effects of simvastatin due to depression of macrophages or lipid accumulation in the atheromatous plaques of coronary plaque-prone WHHL rabbitsAtherosclerosis, 2005
- Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune CellsNew England Journal of Medicine, 2004
- Macrophage/Microglial Accumulation and Proliferating Cell Nuclear Antigen Expression in the Central Nervous System in Human Immunodeficiency Virus EncephalopathyThe American Journal of Pathology, 2004
- Inflammation and cancerNature, 2002
- Injection of human primary effusion lymphoma cells or associated macrophages into severe combined immunodeficient mice causes murine lymphomas.2002
- Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival.International Journal of Oncology, 2000
- IMMUNOCYTOCHEMICAL LOCALIZATION OF ESTROGEN AND PROGESTERONE-RECEPTOR AND PROGNOSIS IN HUMAN PRIMARY BREAST-CANCER1990
- Cytocidal activity and proliferative ability of macrophages infiltrating the EMT6 tumorInternational Journal of Cancer, 1978